Literature DB >> 30915711

Neurodevelopmental Disorders: Functional Role of Ambra1 in Autism and Schizophrenia.

Livia La Barbera1,2, Francescangelo Vedele1,2, Annalisa Nobili1,3, Marcello D'Amelio4,5, Paraskevi Krashia6,7.   

Abstract

The activating molecule in Beclin-1-regulated autophagy (Ambra1) is a highly intrinsically disordered protein best known for its role as a mediator in autophagy, by favoring the formation of autophagosomes. Additional studies have revealed that Ambra1 is able to coordinate cell responses to stress conditions such as starvation, and it actively participates in cell proliferation, cytoskeletal modification, apoptosis, mitochondria removal, and cell cycle downregulation. All these functions highlight the importance of Ambra1 in crucial physiological events, including metabolism, cell death, and cell division. Importantly, Ambra1 is also crucial for proper embryonic development, and its complete absence in knock-out animal models leads to severe brain morphology defects. In line with this, it has recently been implicated in neurodevelopmental disorders affecting humans, particularly autism spectrum disorders and schizophrenia. Here, we discuss the recent links between Ambra1 and neurodevelopment, particularly focusing on its role during the maturation of hippocampal parvalbumin interneurons and its importance for maintaining a proper excitation/inhibition balance in the brain.

Entities:  

Keywords:  Ambra1; Autism spectrum disorder; Autophagy; Excitation/inhibition; Hippocampus; Parvalbumin interneuron; Schizophrenia

Mesh:

Substances:

Year:  2019        PMID: 30915711     DOI: 10.1007/s12035-019-1557-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  4 in total

1.  AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity.

Authors:  Emiliano Maiani; Giacomo Milletti; Francesca Nazio; Søs Grønbæk Holdgaard; Jirina Bartkova; Salvatore Rizza; Valentina Cianfanelli; Mar Lorente; Daniele Simoneschi; Miriam Di Marco; Pasquale D'Acunzo; Luca Di Leo; Rikke Rasmussen; Costanza Montagna; Marilena Raciti; Cristiano De Stefanis; Estibaliz Gabicagogeascoa; Gergely Rona; Nélida Salvador; Emanuela Pupo; Joanna Maria Merchut-Maya; Colin J Daniel; Marianna Carinci; Valeriana Cesarini; Alfie O'sullivan; Yeon-Tae Jeong; Matteo Bordi; Francesco Russo; Silvia Campello; Angela Gallo; Giuseppe Filomeni; Letizia Lanzetti; Rosalie C Sears; Petra Hamerlik; Armando Bartolazzi; Robert E Hynds; David R Pearce; Charles Swanton; Michele Pagano; Guillermo Velasco; Elena Papaleo; Daniela De Zio; Apolinar Maya-Mendoza; Franco Locatelli; Jiri Bartek; Francesco Cecconi
Journal:  Nature       Date:  2021-04-14       Impact factor: 49.962

2.  AMBRA1, Autophagy, and the Extreme Male Brain Theory of Autism.

Authors:  Bernard Crespi; Silven Read; Amy Ly; Peter Hurd
Journal:  Autism Res Treat       Date:  2019-10-10

3.  Prenatal Exposure to Triclocarban Impairs ESR1 Signaling and Disrupts Epigenetic Status in Sex-Specific Ways as Well as Dysregulates the Expression of Neurogenesis- and Neurotransmitter-Related Genes in the Postnatal Mouse Brain.

Authors:  Agnieszka Wnuk; Joanna Rzemieniec; Karolina Przepiórska; Bernadeta Angelika Pietrzak; Marzena Maćkowiak; Małgorzata Kajta
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

4.  Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling.

Authors:  Francesca Nazio; Francesco Cecconi; Agnese Po; Luana Abballe; Claudio Ballabio; Francesca Diomedi Camassei; Matteo Bordi; Antonio Camera; Simona Caruso; Ignazio Caruana; Marco Pezzullo; Caterina Ferraina; Giacomo Milletti; Matteo Gianesello; Sofia Reddel; Carmen Dolores De Luca; Donatella Ceglie; Sara Marinelli; Silvia Campello; Elena Papaleo; Evelina Miele; Antonella Cacchione; Andrea Carai; Maria Vinci; Enrico Velardi; Biagio De Angelis; Luca Tiberi; Concetta Quintarelli; Angela Mastronuzzi; Elisabetta Ferretti; Franco Locatelli
Journal:  Acta Neuropathol       Date:  2021-07-24       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.